ARCHIVES

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

This article is from The Cancer Letter archive.

Vol. 33 No. 18 | May 11, 2007

Download PDF Visit The Full Archive

Related Articles

Abstracts Deadline For Cancer Congress Extended To Dec. 31

December 13, 1985

ASCO Explores White, Minority Cancer Problem

July 13, 1990

Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head.

September 9, 2005

Biotheraputices To Reveal Plans for Expansion

August 8, 1986

Appreciation: Quack-Buster Saul Green Used Science to Debunk Alternative Medicine Claims.

July 13, 2007

In Brief: Ethics Commission To Consider Staff Proposal For Compensation Program At Future Meeting

March 13, 1981